Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neang S Ly

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|April 4, 2012
Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosaNeang S Ly, Jenny Yang, Jurgen B Bulitta, et al.
Clinical Pharmacokinetics|March 4, 2023
Population Pharmacokinetics and Exposure-Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid CancerNeang S Ly, Jing Li, Raffaella Faggioni, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2013
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing designCornelia B Landersdorfer, Neang S Ly, Hongmei Xu, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Pharmacodynamic variability beyond that explained by MICsRachel L Soon, Neang S Ly, Gauri Rao, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosaJürgen B Bulitta, Neang S Ly, Jenny C Yang, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2017
Influence of <i>rhlR</i> and <i>lasR</i> on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with AzithromycinZackery P Bulman, Neang S Ly, Justin R Lenhard, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2016
Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral SurgeryMathias Wittau, Stephan Paschke, Max Kurlbaum, et al.
International Journal of Antimicrobial Agents|January 2, 2017
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changesRajnikant Sharma, Saloni Patel, Cely Abboud, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutatorsZackery P Bulman, Mark D Sutton, Neang S Ly, et al.
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|April 4, 2012
Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosaNeang S Ly, Jenny Yang, Jurgen B Bulitta, et al.
Clinical Pharmacokinetics|March 4, 2023
Population Pharmacokinetics and Exposure-Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid CancerNeang S Ly, Jing Li, Raffaella Faggioni, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2013
Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing designCornelia B Landersdorfer, Neang S Ly, Hongmei Xu, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Pharmacodynamic variability beyond that explained by MICsRachel L Soon, Neang S Ly, Gauri Rao, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosaJürgen B Bulitta, Neang S Ly, Jenny C Yang, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2017
Influence of <i>rhlR</i> and <i>lasR</i> on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with AzithromycinZackery P Bulman, Neang S Ly, Justin R Lenhard, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2016
Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral SurgeryMathias Wittau, Stephan Paschke, Max Kurlbaum, et al.
International Journal of Antimicrobial Agents|January 2, 2017
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changesRajnikant Sharma, Saloni Patel, Cely Abboud, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutatorsZackery P Bulman, Mark D Sutton, Neang S Ly, et al.
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Pageof 2